Atezolizumab,Cabozantinib
Roche
['cabo ', 'atezo']
no difference in the co-primary endpoints of pfs or os between pts. receiving atezo+cabo vs. atezo following prior treatment with icis important data to inform decision making in clinical practice #asco23 
Incoming PGY-1 @BIDMC_IM | Postdoctoral GU Oncology Research Fellow @DanaFarber | MD, Class of 2020 @USJLiban | Interested in Oncology